Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  HCG gains with associate company inking agreement with Quest Diagnostics

11-Oct2018

HCG gains with associate company inking agreement with Quest Diagnostics

Healthcare Global Enterprises is currently trading at Rs. 216.15, up by 1.05 points or 0.49% from its previous closing of Rs. 215.10 on the BSE.

The scrip opened at Rs. 249.00 and has touched a high and low of Rs. 249.00 and Rs. 215.00 respectively. So far 78 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 352.00 on 31-Jan-2018 and a 52 week low of Rs. 200.00 on 03-Oct-2018.

Last one week high and low of the scrip stood at Rs. 249.00 and Rs. 205.45 respectively. The current market cap of the company is Rs. 1888.89 crore.

The promoters holding in the company stood at 24.85%, while Institutions and Non-Institutions held 58.13% and 17.03% respectively.

HealthCare Global Enterprises' (HCG) associate company -- Strand Life Sciences has entered into an agreement to acquire the India medical diagnostics business of Quest Diagnostics, the world's leading provider of diagnostic information services.

The two companies will work together to manage the transition, and aim to close the sale by the end of first quarter of calendar year 2019. This acquisition is an important addition to the company's network of 24 diagnostic labs across India, especially as they continue to expand their work in oncology, genomics, and precision medicine.

HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.


Related News

View all news

Tata Motors rises on launching new top of the line variant -Tiago XZ+

Tata Motors is currently trading at Rs. 159.85, up by 1.65 points or 1.04% from its previous closing of Rs. 158.20 on the BSE.The scrip opened at Rs. 159.90 and has touched a high and low of Rs. 160.25......

Zydus Wellness surges on getting CCI's approval for acquisition of Heinz

Zydus Wellness is currently trading at Rs. 1325.40, up by 21.45 points or 1.65% from its previous closing of Rs. 1303.95 on the BSE.The scrip opened at Rs. 1310.10 and has touched a high and low of Rs.......

Unichem Laboratories soars on getting tentative approval for Tadalafil Tablets

Unichem Laboratories is currently trading at Rs. 194.80, up by 3.55 points or 1.86% from its previous closing of Rs. 191.25 on the BSE.The scrip opened at Rs. 198.05 and has touched a high and low of Rs.......

Top News

View all news

AGC Networks' arm incorporates subsidiary in New Zealand

AGC Networks' wholly owned subsidiary -- AGC Networks Australia Pty, Australia, has incorporated its subsidiary namely 'AGC Networks New Zealand' which is registered with the Registrar of Companies of......

Allium Finance becomes subsidiary of Edelweiss Financial Services

Allium Finance has become a subsidiary of Edelweiss Financial Services, earlier which was an associate company.Edelweiss Financial Services is primarily engaged in the business of rendering merchant banking......

RIL's telecom arm gets nod to transfer its fibre undertaking

Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) has received approval for scheme of arrangement for transfer of its fibre undertaking, on a going concern basis, to a separate company.......